Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Terho Heikkinen a Department of Paediatrics, Turku University
Hospital, FIN-20520 Turku, Finland, b Department of Virology, University of Turku
Correspondence to: T
Heikkinen terho.heikkinen{at}utu.fi
The neuraminidase inhibitors zanamivir and oseltamivir have
been shown to be effective in the treatment of influenza A and B viral
infections. Both of these drugs are ineffective against respiratory
infections caused by other microbes. Although the onset of influenza is
often abrupt with prominent systemic features, the clinical spectrum of
this disease is extremely broad and it cannot be reliably distinguished
from other respiratory infections on clinical grounds
alone.1 To help them decide which patients will benefit
from the new treatments for influenza doctors therefore need rapid and
sensitive point of care tests to verify the cause of the infection.
A nasopharyngeal aspirate is generally considered the best specimen for
detection of influenza viruses,2 but there are few
comparative studies of the effect of sample type on detection of
influenza.
3 4
Collection of a nasopharyngeal aspirate is
unpleasant for the patient and requires a suction device, making it
unfeasible in many clinical situations. We conducted a prospective study comparing the detection rates of influenza in nasal swabs and
nasopharyngeal aspirates obtained at the same time.
The study was carried out during the influenza epidemic of 1998-9 at the department of paediatrics, Turku University Hospital, Finland. A
total of 101 children admitted to hospital with an upper respiratory
tract infection were enrolled. The median age of the children was 13 months (range 2 weeks to 15 years); 53 of them were girls. The study
protocol was approved by the ethics committee of Turku University
Hospital, and oral informed consent was obtained from the parents of
the children.
A nasal swab was obtained from one nostril with a sterile cotton swab,
which was then placed in a dry sterile vial. The nasopharyngeal aspirate was obtained with a disposable catheter (Pennine Healthcare, Derby) connected to a mucus extractor (Maersk Medical, Denmark). The
catheter was inserted into the opposite nostril to a depth of 5-7 cm
and drawn back while applying gentle suction with an electric suction
device. Both specimens were obtained without instillation of any
solution into the nostrils. The specimens were transported to the
laboratory at room temperature and tested for influenza A and B
antigens by time resolved fluoroimmunoassay as described
earlier.5
Of the 101 children enrolled, 23 had influenza viruses detected in the
nasopharyngeal aspirate specimens (table). The nasal swab specimens
showed influenza in 21 of these 23 children, giving a sensitivity of
91% (95% confidence interval 73% to 98%) compared with the aspirate
specimens. No child had influenza detected in only the nasal swab
(specificity 100%; 86% to 100%).
Testing of nasal swabs detected influenza in 21 of the 23 children who were found to have the virus in nasopharyngeal
aspirate specimens. Nasal swab specimens are easy and painless to
collect and require no additional devices. When used with point of care antigen detection tests,4 nasal swab specimens could
therefore help optimise the use of anti-influenza drugs in
everyday clinical practice. Further studies are needed to
determine the usefulness of this approach in adults and with different
viral diagnostic methods.
![]()
Participants, methods, and results
Top
Participants, methods, and...
Comment
References
![]()
Comment
Top
Participants, methods, and...
Comment
References
| |
Acknowledgments |
|---|
Contributors: TH and OR conceived the study, identified the patients, and organised the collection of the samples. AAS was responsible for the laboratory detection of viruses. TH analysed the data and wrote the paper. OR is the guarantor.
| |
Footnotes |
|---|
Funding: This work was supported by the Academy of Finland.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 1999; 28: 283-290[Medline]. |
| 2. | Zambon M. Laboratory diagnosis of influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford: Blackwell Science, 1998:291-313. |
| 3. |
Schmid ML, Kudesia G, Wake S, Read RC.
Prospective comparative study of culture specimens and methods in diagnosing influenza in adults.
BMJ
1998;
316:
275 |
| 4. |
Covalciuc KA, Webb KH, Carlson CA.
Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods.
J Clin Microbiol
1999;
37:
3971-3974 |
| 5. | Nikkari S, Halonen P, Kharitonenkov I, Kivivirta M, Khristova M, Waris M, et al. One-incubation time-resolved fluoroimmunoassay based on monoclonal antibodies in detection of influenza A and B viruses directly in clinical specimens. J Virol Methods 1989; 23: 29-40[Medline]. |
(Accepted 11 September 2000)